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Abstract 
North Carolina (NC) has a prevalence of approximately 36,700 people living with Human 
Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS).  In 2016, there 
was an incidence rate of approximately 1,399 adults and adolescents who were newly diagnosed 
with HIV/AIDS.  NC’s HIV viral suppression rate was at 65%, well below the Joint United 
Nations Programme on HIV/AIDS (UNDAIDS) goal of 90% suppression.  The purpose of this 
project was to implement the University of California –San Francisco (UCSF) Rapid ART 
(Antiretroviral Therapy) Program Initiative for HIV Diagnoses (RAPID) model in a resource 
limited North Carolina public health setting.  The UCSF RAPID care model implementation 
seeks to condense multiple steps for engagement in to care in to one visit resulting in same day 
linkage to care and initiation of ART, a process shown to improve retention in care and decrease 
time to viral suppression.  Clinic staff included: NP (n=5), PA (n=1), MD (n=1), RN (n=2), 
MSW (n=2). Referrals came from STI clinics and outside referrals.  Medication was obtained 
from starter/sample packs, patient assistance programs, HIV Medication Assistance Program 
(HMAP).  Median days from diagnosis to first clinic visit was 17 and 86% of patients started 
ART at first clinic visit.  RAPID implementation results shorter time from diagnosis to first 
clinic visit, decreasing the time to viral suppression. Implementation is feasible and sustainable.   
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Chapter One:  Overview of the Problem of Interest 
According to North Carolina (NC) Public Health (2016), 36,700 people live with human 
immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS).  An estimated 
2,500 individuals were undiagnosed and unaware that they were infected. 1,399 adults and 
adolescents were newly diagnosed with HIV/AIDS, which was higher than the 2015 report.  Of 
those living with HIV in NC, 80% were men who reported having sex with men (MSM), 53% 
were young men aged 13 to 29, while 5% acquired HIV through injection drug use (IVDU) 
(North Carolina Public Health, 2016).   African American gay and bisexual men continue to be 
disproportionately affected by the epidemic, accounting for 39% of all new HIV diagnoses in 
2015.  According to AIDSVu (2018), in 2016, 45%, of all people in the United States diagnosed 
with HIV lived in the South.  To put it another way, almost half of the United States population 
living with HIV lived in the South.  In 2015, there were 3,617 people diagnosed with HIV and 
132 new cases in North Carolina’s Wake County (AIDSVu, 2018).  In 2017, the Wake County 
Health Department received 193 new HIV patients (Wake County Human Services, 2017).  Of 
those 193, 62 were newly diagnosed with HIV (Wake County Human Services, 2017). The 
purpose of this chapter is to describe the importance of beginning care as soon as possible after 
HIV diagnosis.  
   Furthermore, a National Institutes of Allergy and Infectious Disease (NIAID)-
funded study, the Strategic Timing of AntiRetroviral Treatment (START), definitively answered 
the question of whether starting antiretroviral therapy (ART) sooner is better than delaying until 
CD4+ T-Cell count dropped (INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., 
Gordin, F., Emery, S., Grund, B., et al. (2015).  The answer favored starting ART as soon as 
possible (INSIGHT START Study Group et al., 2015).  According to this NIAID study, 
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individuals who start earlier ART have a reduced risk for progressing to acquired 
immunodeficiency virus (AIDS) or acquiring comorbidities when compared to individuals who 
do wait until CD4+ T-cell counts drop.  This NIAID study, along with data from additional 
studies (Cohen et al., 2011), indicated that HIV transmission to uninfected sexual partners was 
also reduced by the infected partner’s treatment. In summary, clinical trials have demonstrated 
that individuals starting ART immediately after diagnosis had better health outcomes among 
patients and their partners than if patients delayed ART (INSIGHT START Study Group, 
Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., et al. 2015).  Therefore, 
individuals should begin treatment as soon as possible to achieve viral suppression.  
Alternatively, individuals who present late to HIV specialist care are often ill, are less likely to 
respond to treatment when initiated and have high morbidity and mortality rates (Girardi, Sabin, 
& Monforte, 2007). 
While some individuals living with HIV have insurance, many do not (Wake County 
Human Services, 2017).  The uninsured depend on the HIV Medication Assistance Program 
(HMAP) as the payer source for ART.  ADAP coverage services, processing steps, and approval 
times vary from state to state.  In North Carolina, approval times range from 2 to 4 weeks, with 
up to a 4-week delay before starting ART (J. Lambert, personal communication, July 20, 2018).  
Even with insurance, prior authorizations may delay time until a patient can start ART.  An 
additional problem is the delay between time of diagnosis until presentation to HIV care.  
Referral to an HIV specialist depends on when an appointment can be made, which could take 
days to months. 
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Significance of Clinical Problem  
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a goal within 
their 90-90-90 campaign (Joint United Nations Programme on HIV/AIDS, 2013).  That is: (1) 
90% of all people living with HIV will know their HIV status by 2020, (2) 90% of all people 
with diagnosed HIV infection will receive sustained antiretroviral therapy by 2020, (3) 90% of 
all people receiving antiretroviral therapy will have viral suppression by 2020.  According to the 
Health Equity and HIV in North Carolina report (North Carolina Public Health, 2016), gay, 
bisexual, and other men who have sex with men (MSM) of color have the highest HIV rates in 
North Carolina.  Once in treatment, however, disparity in care outcomes decreases.  Viral 
suppression is one result of successful treatment care outcome.  Although North Carolina has 
made progress, its viral suppression rate of 65% (North Carolina Public Health, 2016) falls 
below UNAIDS’s 90% suppression rate goal.      
Question Guiding Inquiry (PICO)  
Is it possible to successfully implement the RAPID care model in a North Carolina public 
health setting?  
Population.   
 The population included individuals who received a new diagnosis of HIV and were 
treatment naïve.  The project site clinic provides care to individuals aged 18 years through end of 
life.  The entirety of this age range was eligible for project inclusion.  
Intervention.   
The intervention consisted of (1) same day appointments for individuals newly diagnosed 
with HIV and (2) same day initiation of ART.  Staff meetings incorporated explanations of the 
RAPID care model.  Clinic staff included nurses, nurse practitioners, social workers, 
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phlebotomists, and disease intervention specialists.  All staff in the sexually transmitted infection 
clinic (where HIV testing takes place) and field-testing sites must be alert for anyone with a 
positive test, and for those people to be escorted to the HIV clinic for immediate initiation of 
care.  These two clinics are located within the same building and connected to each other.  
Comparison.   
The data from those individuals who participate in the project will be compared to pre- 
intervention data. Specifically, the time to first appointment and initiation of therapy will be 
evaluated. Prior to implementation, no standard was in place for same day appointments or 
treatment initiation.  
Outcome.   
The target outcome for this project was to implement same day ART therapy.  This was 
measured by counting how many patients in the RAPID care group were diagnosed and seen for 
a first clinic visit on the same day.  In addition, participants who were  started on ART the same 
day as their first clinic visit was measured.  
Summary  
 Although global goals have been set to diminish HIV’s impact, HIV acquisition and 
transmission continues in North Carolina, with disproportionate occurrences in some groups.  
Prompt ART initiation in individuals with newly diagnosed HIV is important for individuals’ 
health and for reducing HIV transmission.   The RAPID care model, a model of same day testing 
and treating, has been demonstrated to be both safe and effective for individuals newly 
diagnosed with HIV (Pilcher et al., 2017).  
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Chapter Two:  Review of the Literature 
Literature Review Findings  
 This review included systematic reviews and meta-analyses, randomized controlled trials, 
cohort studies, and descriptive studies.  Most of these studies involved discussion about 
intervention with ART.  AIDS defining events and CD4 T cell count were often used as end 
markers for evaluation. In some publications, viral load was used to stratify the data.  Of 
importance, there was no contemporary data indicating that a delay of ART initiation benefitted 
patients in the general population. 
Methodology 
Sampling strategies.  
 PubMed was the primary database used to find peer- reviewed articles for this project.  
These were accessed through East Carolina University’s Laupus Library website.  Key words 
used included: HIV antiretroviral therapy rapid start (67 results), HIV rapid start (141 results) 
and rapid ART start (51 results).  Combined, these resulted in a total of 259 results with multiple 
types of articles, including randomized trials and meta-analyses.  Reference lists from the initial 
articles were reviewed to expand the search.  In particular, the protocol that this quality 
improvement project is guided by is based on Pilcher et al.’s (2017) publication.  To obtain 
current local surveillance data and demographics, unpublished data was obtained from the Wake 
County Health Department (Wake County Human Services, 2017).   
Evaluation criteria.  
Forty-four articles were subsequently selected, with fifteen included in the final literature 
review after exclusion/inclusion criteria were applied. These 15 articles were selected after 
reading them individually for relevance to the project.  In addition, two government websites, 
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one unpublished data source from a county health department were included.   Only articles 
published within the last five years were included.  Exceptions were made for articles of 
relevance or where more recent data was not available.  Special attention was given to articles 
that compared outcomes between early initiation to late initiation of ART.  Exclusions were 
made for articles that did not address either initiation of ART timing or the resulting outcomes.  
Articles were excluded that did not support the project.  Relevance was defined as a publication’s 
ability to provide meaningful contribution to the body of knowledge surrounding timing of ART 
initiation.  
Literature Review 
Importance of Early Treatment 
Early ART initiation is imperative to improving morbidity and mortality in individuals 
diagnosed with HIV (Ananworanich et al., 2013; Grinsztejn et al., 2014; Zolopa et al., 2009). 
Ananworanich et al. (2013) included 47 participants in their study of early ART treatment. Early 
ART resulted in low reservoir size and absence of detectable HIV- integrated DNA in PMBC 
and memory CD4-T cells. This study indicated that early intervention resulted in the CD4 cells 
seeding the HIV reservoir.  In a sub-Saharan Africa setting, Danel et al., (2015) found that 
immediately starting ART with isoniazid (IPT) preventive therapy resulted in lower rates of 
severe illness than if ART and IPT was deferred.   
Grinsztejn et al. (2014) enrolled 1,763 HIV-1 infected serodiscordant couples, (a couple 
in which one individual is HIV positive and one individual is HIV negative,) and assigned them 
to either early or delayed antiretroviral treatment (at the time of their research the optimal time to 
initiate ART was still being evaluated in the scientific community).  The study demonstrated that 
early initiation of ART delayed length of time to an AIDS event (examples including 
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tuberculosis and severe bacterial infections) and incidence of other outcomes including stage 2,3, 
and 4 HIV-1 and death.     
Zolopa et al. (2009), studied differences between individuals randomized to either early 
ART given within 14 days of starting opportunistic infection (OI) treatment or deferred ART 
after OI treatment was completed.  The group that received early ART encountered less AIDS 
progression/death or loss of virologic response when compared to participants who received 
deferred ART.   De Cock and El-Sadr (2013) described that immunologic recovery will lag if 
ART is delayed and that uncontrolled HIV replication results in immune activation and 
inflammation.   
Viral suppression has been found across multiple studies to reduce HIV transmission risk 
among serodiscordant couples (Cohen, et al., 2011; Grinsztejn et al., 2014). Grinsztejn et al. 
(2014) found that early ART treatment reduced HIV-1 transmission by 96%. The median age 
was 33, with half of the study participants being men. Their study included 1,763 couples that 
included a serodiscordant partner, with 886 assigned to the early treatment arm and 877 assigned 
to the delayed treatment group.  Early ART started at study enrollment while delayed ART began 
after two consecutive CD4 counts at or below 250.    Early ART treatment reduced transmission 
rates and extended time to first clinical event among treatment group versus delayed treatment 
group (Grinsztejin et al., 2014).   Additionally, it was found that early ART resulted in an HIV 
transmission incident rate of 1.2 per 100 person years, which was calculated using the Kaplan-
Meier method, across both early and delayed ART initiation (Cohen et al., 2011).  The early 
therapy group showed an incidence rate of 0.3 per 100-person years (4 events) while the delayed 
therapy group had an incidence rate of 2.2 per 100-person years (35 events).  The early ART 
initiation group demonstrated a reduction of HIV-1 related clinical events by 41% in comparison 
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to the delayed ART initiation group.  This finding supports early treatment with ART for HIV-
infected persons, even with high CD4 count, with the effect of reducing transmission rates and 
decreasing clinical events.    
Jain et al. (2013) suggested that ART, begun within 6 months of infection with HIV, is 
associated with a lower T-cell (CD4) activation and smaller HIV reservoir size than if begun 
after 2 or more years.  The researchers examined a cohort of HIV patients who either began ART 
early (<6 months after infection) or later (2 or more years after infection) and who maintained 
two or more years of viral suppression.  Demographics were men with median ages from 33 to 
38 whose primary HIV risk factor was having sex with other men. Early ART was associated 
with lower CD4 T-Cell activation than in later ART group (5.3% vs 7.5%; P = 0.06).  Early ART 
was also associated with a 4.8 x lower DNA level than found in the later ART participants 
(P=0.005).   
The Writing Committee for the CASCADE Collaboration (2011) conducted an 
observational study with 9,455 patients on the effect of delaying ART.  Most participants were 
men who acquired HIV from having sex with other men. Median age at seroconversion was 30.3.  
When results were stratified by CD4 counts of 200-349, 350-599, and 500-799, ART initiation at 
a CD4 counts <500 was correlated with slower disease progression when compared to deferring 
ART start within a given month   
Contemporary Models of Early Initiation 
 Pilcher et al. (2017) described the hurdles that complicate rapid initiation of HIV 
treatment, including structural barriers, patient attitudes and provider attitudes. They wrote that 
testing sites and care sites are often in different locations leading to delays up to weeks before 
initiating care.  Obtaining health insurance benefits to pay for treatment further complicate 
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treatment initiation.  When an appointment is made, factors take priority over ART initiation, 
such as initial labs, post-test counseling and education, management of housing or substance 
abuse.  In addition, Pilcher et al. (2017) explained that some healthcare providers defer ART 
until patients prove they can adhere to treatment by attending multiple appointments.  
 To address these issues, a clinical health systems intervention was launched by the San 
Francisco General Hospital HIV clinic, RAPID (Rapid ART Program for Individuals with an 
HIV Diagnosis).  The aim of RAPID was to simplify ART initiation for individuals newly 
diagnosed with HIV by starting ART on the same day referred for care (Pilcher et al., 2017).  Of 
39 eligible patients who were managed on the RAPID protocol, 37 were started on ART within 
24 hours.  Minor toxicities were observed in only 2 (5.1%) from the intervention group in 
comparison to none in the non-intervention group.  Additional studies have also reported that 
laboratory marker toxicities are low for both early and delayed ART start groups (Cohen, et al., 
2011). Pilcher et al. (2017) also demonstrated that the time to virologic suppression (<200 HIV 
RNA/mL) was significantly faster (median 1.8 months) for those participants enrolled on the 
intervention arm versus those treated with previous recommendations for universal ART (4.3 
months).  Support that immediate ART initiation vs delayed initiation decreases time to viral 
suppression has been demonstrated across other studies as well (Lodi, et al., 2015; Pilcher et al., 
2017). 
Transmission Rates 
 There are many benefits to a RAPID approach.  Among these are a reduction in HIV 
reservoir size (the small persistent collection of latently infected cells in individuals infected with 
HIV) in acute infection settings (Ananworanich, et al., 2013; Jain, et al. 2013), decreased 
complications, and elimination of transmission during the acute phase (Bellan, Dushoff, Galvani, 
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& Meyers, 2015; Brenner et al., 2011; Hollingsworth, Pilcher, Hecht, Deeks, & Fraser, 2015; 
Pilcher et al., 2007; Wawer et al., 2005). From an epidemiologic standpoint, factors that may be 
driving and contributing to the transmission of HIV in urban settings include being in a large 
cluster group which include >10 sexual partners versus those in smaller clusters with fewer 
sexual partners (Brenner et al., 2011).  However, it should be noted that Brenner et al. (2011) 
have shown that small cluster groups also report higher anal-insertive risk activities than their 
large-cluster counterparts.   
 Bellan et al. (2015) estimated based on viral load-infectivity that the chance of 
transmission at peak viral load during acute phase is approximately nine times greater than at the 
chronic phase set point.  The researchers also estimated the median transmission rate between 
partners to be 12 (4.6 – 30) per 100 person-years with the heterogeneity in transmission to be 2 
(1.2 – 2.8).  According to their report, “2” corresponds to individuals at the 97.5% quantile 
(highest risk) having a 50-fold greater transmission rate than the median.  Wawer et al. (2005) 
wrote that HIV transmission per coital act were highest during early-stage infection.  This 
observation is an indication for early ART treatment.  Early treatment with ART is also 
associated with reduced morbidity and mortality in individuals with HIV infection (Pilcher et al., 
2007).    
Limitations of Literature Review Process  
 Because confirmation of early treatment importance and evidence of efficacy of the 
RAPID model emerged in the last 5 years, there are limited peer-reviewed journal articles.  
There is also a still small, but growing, number of rapid start protocols that are being used across 
the United States, each varying to accommodate the needs of the respective locations that they 
were created for (Pilcher et al. 2017; Florida Division of Health, 2018).  Because rapid start 
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protocols are historically developed to accommodate specific healthcare systems, they may 
potentially not be effectively implemented in their entirety in a given health care setting.  
Financial resources are also a noticeable factor that may reveal variation between the health 
system a protocol was intended for and an outside system.   
Discussion 
Conclusion of findings.  
The literature suggests that ART initiation should happen as soon as possible after 
diagnosis of HIV (INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., 
Emery, S., Grund, B., et al. (2015).  Additionally, rapid ART start is both feasible and tenable 
(Pilcher et al., 2017). It could potentially be a worthwhile endeavor for clinics in public health 
settings to implement test and treat protocols. The RAPID care model is a recent model 
indicating safety and efficacy (Pilcher et al., 2017).  Given these literature findings, the RAPID 
care model was chosen for this project.  
Advantages and disadvantages of findings.   
Early initiation of ART is the preferred approach versus a delay in initiation.  Early 
implementation helps individuals living with HIV to maintain a better quality of health and avoid 
potential illnesses.  The RAPID protocol developed by Pilcher et al. (2017) specifically showed 
that rapid ART initiation achieves faster time to viral suppression and better adherence 
outcomes.  Specifically, Pilcher et al.’s (2017) design which included a red-carpet process for 
engagement in to care and initiation of ART will be an advantage.  Their model also includes 
providing transportation for the first visit which provides additional advantage for patients who 
are transportation limited.  These factors will also be advantageous to the affected population, 
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which is primarily comprised of men who have sex with men.  However, heterosexual couples, 
too, will benefit, as well as a diverse age range, from 18 years of age and up.  
 Disadvantages described in the literature appear to be more theoretical based on 
perceived structural barriers, barriers that more so describe limitations to executing a rapid start 
(financial resources, access to medication, and policies/procedures) versus a disadvantage for the 
patient.  International studies, in particular those in sub Saharan Africa, provide environments 
that are unique and varied in comparison to the study locations in the United States.  Resource 
limited locations, in general, present with their own unique challenges that are not often faced in 
the United States, including financial limitations, limited access to the latest technology 
innovations, and a less developed and established healthcare infrastructure.   However, most 
studies involving exploration of transmissibility, viral suppression, and negative outcomes are 
generalizable to the United States.  The majority of studies reviewed did provide inferential 
statistics, which does allow them to be generalized to the general public.  
Utilization of findings in practice.  
Implementation of the RAPID protocol may vary and look different from clinic to clinic.  
However, the model has demonstrated efficacy. Thus, clinics should attempt to find a process 
that may be operationalized in their practice setting.   Given the resource differences between the 
line by line specifics of the RAPID care model and what is available at the project 
implementation site, the project site will adapt, staying as true as possible to the RAPID care 
model for the promotion of fast, efficient, and effective engagement in to care.  
Summary  
Recent findings are reshaping the landscape of HIV care.  Antiretroviral therapy should 
be offered immediately to all individuals with HIV. A rapid start approach for those with newly 
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diagnosed or untreated HIV has been shown to improve morbidity and mortality.  Achieving a 
rapid start program in the public health setting is possible, sustainable, and in line with current 
best practices. 
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Chapter Three:  Theory and Concept Model for Evidence-based Practice 
Theoretical Framework  
Described as having written one of the most intellectually challenging pieces on 
American politics, Kingdon sought to explore the process that occurs prior to decision making 
(Quirk, 1986).  According to Quirk (1986), Kingdom sought to understand why some items 
make it on to agendas while others do not.  In Kingdon’s Alternatives and Public Policies, as 
reported by Mooney & Evans (2007), he illustrated a model of agenda setting that includes three 
separate streams, each operating relatively independently from the other.  To reach this 
discovery, Kingdon modified a garbage can model which described a policy agenda as being 
constructed from three process streams, these streams being primarily concerned with problems, 
policies, and politics (Quirk, 1986).  In contrast to the garbage can model, Kingdon’s views of 
decision making suggest that the three streams were overall independent, each following its own 
course and responding to its own influences (Quirk, 1986).  
Within the first stream, a person becomes occupied with, and aware of, the problem, 
partly through the monitoring of systematic indicators (Kingdon & Thurber, 1984).  However, 
they can also emerge with less organization and more unpredictability in events like disasters or 
crises.  Kingdon suggests that subtleties of this process will have a powerful effect primarily 
when the item takes a problem and provides additional support for problems’ perceptions that 
already exist (Kingdon & Thurber, 1984).  
According to Quirk (1986), Kingdon’s second stream involves the process of forming 
and providing revisions to a particular policy proposal.  Within this process, ideas are invented, 
researched, and amended mostly by experts working in loosely organized policy communities 
(Kingdon & Thurber, 1984).  These ideas may be offered several times before they are ever 
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taken seriously; a time referred to as softening-up (Kingdon & Thurber, 1984).  Most of the ideas 
will die out during this time; the ideas that meet criteria for survival will be the ones that succeed 
(Kingdon & Thurber, 1984).  According to Kingdon (1995), some of the criteria are defined and 
enforced by the policy community itself; some of these criteria may include technical feasibility, 
value acceptability, and anticipation of future constraints.  Technical feasibility describes 
whether the idea is fully worked out and whether there is a practical and attainable 
implementation plan (Kingdon, 1995). Value acceptability is primarily concerned with an item’s 
compatibility within the values of the policy community.  Anticipation of future constraints is 
characterized by the notion that the idea must be viewed to have potential, to have reasonable 
budgetary costs and have prospects of approval from politicians, and the public (Kingdon, 1995). 
Lastly, there is a political stream comprised of other categories such as public mood, pressure 
group campaigns, election results, partisan or ideological distributions, and changes of 
administration or legislative turnover.  Any one of these may levy large effects on the agenda 
(Hodge, 2006).  
 Application to practice change. 
The first stream (recognition of the problem) is characterized by awareness that there is a 
need to start individuals living with HIV on ART as soon as possible, although this may be a 
slow process.  The second stream is represented by healthcare organizations recognizing a need 
and changing their healthcare policies, as well as most notably Pilcher’s et al.’s (2017) RAPID 
model previously described. The culture shift occurring where providers are becoming more 
amenable to the RAPID model represents the third stream.  In addition, pharmaceutical 
companies are responding to pressure to provide means for patients to quickly access ART.  At 
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the present time, each of these streams are converging, providing an optimal time to engage and 
initiate a rapid ART start program in a NC public health setting.   
Concept Analysis 
The concept introduced in this quality improvement project is the RAPID start protocol.   
Developed by Pilcher et al. (2017), its aim is to start individuals on ART as soon as possible after 
a new diagnosis of HIV.  Their work has shown rapid ART starts to be both save and effective.  
The ART component of the protocol references the HIV treatment aspect of the protocol.  
Furthermore, it illustrates that this protocol is specifically designed for individuals diagnosed 
with HIV.  Going a step further, it is applied to individuals who are newly diagnosed (by rapid or 
confirmatory HIV test) and treatment naïve, meaning that the individual had never previously 
taken ART.   
EBP Change Theory  
Adoption of innovation has been studied as a concept for over 30 years. One of the most 
popular models is Rogers 2002, Diffusion of Innovations (Shahin, 2006).  Diffusion of 
innovations has been applied to a broad spectrum of occupations (Dooley, 1999; Stuart, 2002).   
Rogers uses the terms “technology” and “innovation” interchangeably. Rogers defines 
technology as a “design for instrumental action that reduces the uncertainty in the cause-effect 
relationships involved in achieving a desired outcome (Rogers, 2003, p. 13).  Rogers (2003) also 
describes innovation as an idea or concept that is perceived as new by the individual who will 
adopt it.  Even if the idea or concept was invented long ago, if it is new to the individual, it may 
be received as innovation.   
According to Rogers, “adoption is a full use of an innovation as the best course of action 
available” (Rogers, 2002, p. 177).  Lastly, diffusion is defined by Rogers as “the process in 
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which an innovation is communicated through certain channels over time among the members of 
a social system” (Rogers, 2003, p. 5).   
Rogers’ Four Concepts 
These four concepts, innovation, communication channels, time, and social system, form 
the diffusion of innovations theory (Rogers, 2003; Sahin, 2006).  Rogers (2003) also suggested 
that uncertainty may be a barrier to the adoption of innovations.  To mitigate uncertainty, he 
advises that individuals be informed about advantages and disadvantages.  Consequences may 
also be classified into the following categories: desirable versus undesirable (functional or 
dysfunctional), direct versus indirect (immediate result or result of the immediate result) and 
anticipated versus unanticipated (recognized and intended or not) (Sahin, 2006). 
 Rogers (2003,) described communication as a “process in which participants create and 
share information with one another in order to reach a mutual understanding” (p.5), with this 
communication occurring through channels between different sources (Rogers, 2003; Sahin, 
2006).   Rogers (2003) elaborated that diffusion is a special kind of communication that includes: 
an innovation, two individuals or other units of adoption, and a communication channel.  Rogers 
also describes diffusion as a social process characterized by interpersonal communication 
relationships (Rogers, 2003).  Thus, interpersonal channels are powerful in creating or changing 
strong individual attitudes.   
 Rogers’ 5 Steps 
       Rogers’ (2003) innovation-decision process involves five steps: 1) knowledge, 2) 
persuasion, 3) decision, 4) implementation and 5) confirmation.  As a routine, these steps usually 
occur sequentially (Rogers, 2003; Sahin, 2006).  It is within the knowledge stage where an 
individual learns about an innovation’s existence.   During the knowledge step, questions of 
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“what?”, “how?”, and “why?” are critical (Rogers, 2003).  It is also during this step that the 
individual is seeking to learn how and why an innovation works (Rogers, 2003).  
 The persuasion stage occurs when an individual develops a negative or positive attitude 
about an innovation (Rogers, 2003).  Because this stage is more affective, with more emphasis 
on personal feelings, individuals deal more sensitively with the innovation during the persuasion 
stage (Sahin, 2006), this means that there is more room for personal feelings to be involved 
during the persuasion stage.  Social influence about the proposed innovation may also impact an 
individual’s beliefs about an innovation (Rogers, 2003).  
 It is during the decision stage in which the individual makes a choice to adopt or reject 
the innovation (Rogers, 2003).  When an innovation has a partial trial basis, the usual outcome is 
that the innovation is adopted quicker (Rogers, 2003).  While adoption is hoped for, rejection is 
possible at any stage of the process (Rogers, 2003).  Rejection may manifest as either active or 
passive rejection.  In active rejection the individual tries an innovation but later decides against 
adopting it.  When an individual does not even think about adopting the innovation, passive 
rejection occurs (Rogers, 2003).  
 When an innovation has been put into practice, the implementation stage has been 
reached (Rogers, 2003).  At this stage, uncertainties about the outcomes of the innovation may 
still be a problem.  During this stage the individual implementing the innovation may benefit 
from support from change agents or other individuals to mitigate uncertainties within an 
organization about the potential consequences (Rogers, 2003).  Once the innovation has reached 
this stage it also transitions away from being an innovation since its distinctive newness wears 
off (Rogers, 2003).  As time goes on and users adopt the innovation, reinvention may occur, 
which is a process by which the innovation is changed or modified (Rogers, 2003). 
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 The confirmation stage is characterized by the innovation-decision having already been 
made (Rogers, 2003).  During this stage the individual looks for support for their decision.  If 
exposed to conflicting messages within an organization, the decision to adopt the innovation may 
even be reversed (Rogers, 2003).  Because the individual will seek supportive messages that 
confirm their decision, attitudes become a more crucial factor.  The following support for the 
adoption of the innovation can impact future adoption or discontinuance (Sahin, 2006).    
Evidence Based Practice Model Application 
 Each of Roger’s five steps will be utilized in the successful implementation of this quality 
improvement project.  The knowledge stage was characterized by multiple individual and group 
meetings which answered the questions of how, what, and why.  To help reduce uncertainty, the 
staff was informed about advantages and disadvantages.  Staff involved was given a chance to 
ask questions and understand the basic constructs of the RAPID care model.  As staff wrestled 
through their feelings of support or skepticism about the project they journeyed through the stage 
of persuasion.  As staff eventually accepted and supported the project they moved through the 
decision stage. Once the project has been put in to place the innovation stage will be manifested. 
The confirmation stage will commence once the project is implemented and support is sought 
after to affirm the success of the project.  
Summary  
Considering that the RAPID ART initiation model is relatively new to NC public health 
settings, adoption of the model must occur.  A persuasion stage must happen prior to project 
implementation.  During this phase, the clinic staff and stakeholders will need to be persuaded 
about importance of prompt ART initiation.  The decision stage will be critical, in that successful 
implementation will depend upon whether the involved individuals have committed to support 
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the RAPID model.  Once implementation occurs, it will provide an innovative, new concept 
within the NC public health system, allowing prompt ART initiation.   Whether the innovation 
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Chapter Four:  Pre-implementation Planning 
The following chapters describe the pre-implementation planning process for quality 
improvement project in a public health setting in the southeastern United States.   
Project Purpose  
 The purpose of this quality improvement project was to implement the RAPID Care 
Model in a southern state public health setting. It aimed to provide a same day appointment for 
individuals who were newly diagnosed with HIV.  In addition, same day ART initiation was 
offered and provided when clinically appropriate.   The primary idea was to simplify the multiple 
steps individuals routinely encountered in their journey to care and treatment and create an easy 
on ramp to engagement in care.  
Project Management 
Organizational readiness for change 
The Health Department was ready for this organizational change. Historical structural 
barriers, such as availability of an ART supply in clinic and cost of medication, had been 
overcome and no longer presented the resistance to rapid care that they once did.  Specifically, 
pharmaceutical companies had been working with the Health Department to provide starter 
packs of ART, which were accessed by the patient on the same day as diagnosis.  In addition, 
administrative, clinical, and support staff were educated, had taken interest in the rapid start 
process and were aware of the public health benefit, including improved retention in to care and 
faster time to viral suppression.  Meetings were scheduled with upper administration to help 
coordinate all stakeholders and staff to provide patients quick entry to care after diagnosis.  
Administrative staff had demonstrated enthusiasm in backing the implementation of the RAPID 
care model.  
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Inter-professional collaboration.  
A multidisciplinary approach was necessary for the RAPID Care model to be 
successfully implemented and was be highlighted by the need for successful transitions and 
hand-offs. When diagnosed at the initial clinic, a nurse or nurse practitioner would personally 
walk the patient over to the second clinic and assisted the patient with accessing immediate care.  
When a patient was diagnosed at a site outside of the Health Department, a Disease Intervention 
Specialist would offer the patient a same day appointment and, if accepted by the patient, would 
notify the clinic to schedule an immediate same-day appointment.  A social worker visited with 
the patient and communicated with clinical staff relevant findings to augment care.  Case 
managers were called upon to assist in coordinating transportation for patients to their first clinic 
appointment.  Laboratory phlebotomists provided services for obtaining and processing labs.  
Risk management assessment.   
The organization did have the necessary skills in-house, including clinical expertise, 
social work, case management, and lab processing.  The budget allowed for successful 
implementation of this quality improvement project.  An application was submitted for grant 
funding to provide transportation and additional case management services; at the time of this 
document the result of the application had not yet been determined. Consistent with previous 
publications, the health department benefited from increased patient retention in to care.  No new 
equipment or technology was required. The team involved was able to provide expert leadership 
and clinical expertise in the implementation of this quality improvement project.  
The project did not incur additional costs for the operations of the clinic.  Through Ryan 
White federal funding, the clinic did have funds to help newly diagnosed patients receive care.  
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A drawback of the project included additional time burden on staff.  No part of this project 
needed to be outsourced.  
Organizational approval process.   
Multiple individual and group meetings were held to get leaders on board.  This included 
casual informal, impromptu meetings, formal gatherings to brainstorm, and boardroom 
presentations to present and answer questions.  Special attention was given to include direct 
stakeholders who both directly and indirectly benefited.  Each meeting garnered additional 
support and enthusiasm for the potential of the project. Primarily the latest evidence-based 
information was presented during each interaction.  The capstone of the organization approval 
process was approval by the organization’s research review board. Prior to approval, a meeting 
with department administrative personnel was held and there was unanimous favor for 
implementing this quality improvement project. Approval was granted via verbal affirmation 
(Appendix B).  
Information technology.  
Information technology utilized in this project included electronic resources, including 
electronic medical records, and computer software.  Hardware included computers for data 
processing and phones for communication.   
Cost Analysis of Materials Needed for Project 
Antiretroviral therapy costs vary, although the average cost of a first line regimen is 
$3,500 for a 30-day supply.  Because samples of product were supplied for starter packs, as well 
as use of patient assistance programs, there was no charge incurred to the clinic.  The cost of 
transportation was estimated to be at $2,880 to provide transportation to and from the first two 
clinic visits for 30 people.  A grant was submitted to help cover the cost of transportation.  An 
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additional $19,094 was requested in the form of a grant to provide support for additional for a 
peer educator, as well as $654 for the peer educator to drive to a patient if needed. Ultimately, 
funds were not obtained from this grant and external funding sources were not utilized as part of 
this project.  
Plans for Institutional Review Board Approval 
 The UW-Madison QI/Program Evaluation Self-Certification Tool was used to assess the 
need for IRB approval, which per East Carolina University was categorized as a quality 
improvement project and not human research.  In result, full IRB review was not needed.  This 
information (Appendix C) was then submitted to the Wake County Human Services research 
review board for their verbal approval.  
Plan for Project Evaluation 
Demographics.   
In order to describe the participants involved in this quality improvement project, the following 
demographic data was collected via the data collection tool (Appendix D): age, gender, and race. 
Age was reported as a mean, mode, and standard deviation.  Race and gender were statistically 
processed as nominal data.  This data was presented in figures, tables, and graphs as appropriate.  
Outcome measurement.  
The first outcome measurement was the number of patients who were seen for clinical 
care the same day that they receive a HIV diagnosis.  In terms of the project, this was the 
component of the RAPID protocol that aimed to streamline entry in to care.  The second 
outcome measured was the number of patients who were started on ART the same day as their 
first appointment.  This too was a component of the RAPID protocol that aimed to initiate 
patients on ART as soon as possible.   
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Evaluation tool.   
For the purpose of measuring primary outcomes, specific information was collected.  
This included whether an appointment was scheduled and kept for the same day as diagnosis, 
whether ART was started on the same day as the first clinic visit, and the mode of referral to the 
HIV clinic.  The data collection tool used to collect this data is noted in Appendix D.  
Data analysis.    
Measures of central tendency were used to analyze demographic and project specific data 
when appropriate. Generally, descriptive statistics were used for analyzing the project data.  
SPSS served as the statistical software for analyzing the data collected.  
Data management.   
Microsoft Excel served as the spreadsheet on which data was entered and managed. The 
spreadsheet was housed on a computer that was password protected and secured in a locked 
office.  Data was kept for 6 months after project closure or expiration of IRB approval.  Hard 
copy data was destroyed via shredding.  Digital copies were completely deleted from the storage 
computer.  
Summary 
 In summary, demographic, as well as project specific data were collected.  A project data 
collection tool was used to collect the data.  The data was described using measures of central 
tendency and descriptive statistics. Data was managed with an Excel spreadsheet that was 
securely stored to protect patient information. Excel and SPSS served as the software for running 
statistical analysis. 
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Chapter Five: Implementation Process 
The implementation process was characterized by professional collaboration across 
multiple disciplines, including nursing, medical, allied health, and administrative contributors.  
The setting included a public health setting with participants who were newly diagnosed with 
HIV.  
Setting 
 A public health center located in a southeastern state served as the project setting.  
Specifically, the clinic was located within a public health center that serves and cares for 
individuals diagnosed with HIV, including provision of primary care. Five nurse practitioners, 
two nurses, one physician assistant, and one physician staffed the clinic. In addition, the clinic 
had on staff two social workers, one referral coordinator, two patient advocates, two therapists, 
and one psychiatrist. The clinic had eight exam rooms.  It had an adjacent phlebotomy lab, which 
was a short walk from the clinic, where in-house HIV testing occurred. The public health center 
was located on major bus lines and next door to a major hospital.   
Participants 
Participants were included from a population of new and newly diagnosed HIV cases 
registered for care in a southeastern state public health setting. Excluded were participants who 
were not new and newly diagnosed, and those individuals who do not wish to engage in care.  
Recruitment 
 Participation in this quality improvement project was offered to everyone who presented 
to the clinic as new and newly diagnosed with HIV.   Because this was a quality improvement 
project, no informed consent was needed.  However, participants did have the benefits of rapid 
ART start explained to them as part of standard counseling and education during their first visit.  
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They also had alternative options explained so that they were able to make an informed decision 
about their health care.  Alternative options included deferral or transfer of care and deferral of 
ART initiation.     
Implementation  
Process implementation occurred for 12 weeks.   Any time a positive HIV test resulted at 
the southeastern state public health clinic, or at any other ambulatory site within the county, 
participants were offered a same day visit at the clinic.  Following the algorithm of the RAPID 
care model (Appendix E), participants met with a clinician who initiated care and, when 
appropriate, started them on ART the same day. During the course of the initial visit they had 
labs drawn, including complete blood count, chemistry panel, human leukocyte antigen (HLA) 
B5701, hepatitis panel, lymphocyte/CD4 count, viral load, HIV 1 and 2 differentiation, HIV 
genotype, HSV 1 and 2 antibody, hemoglobin A1C, glucose-6-phosphate-dehydrogenase 
(G6PD), toxoplasma antibody, cytomegalovirus antibody, lipid panel, RPR, 
chlamydia/gonorrhea nucleic acid amplification testing.  These labs were part of the current 
standard of practice therefore obtaining them did not incur any additional costs. Finally, they 
were seen by a staff representative to complete registration at the clinic and process financial 
paperwork (Appendices E and F). 
Plan Variation 
The RAPID care model in its original form provided for transportation to and from the 
first clinic visit.  At the time of this documentation a grant request had been submitted to provide 
for transportation, however it had not yet been approved at the time of study implementation. 
The RAPID care model also indicated that a social worker would meet with the patient at the 
first visit. Due to scheduling availability, and newness of the concept, a social worker was not 
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always available during the first visit.  Lastly, given the resource-limited environment of the 
project implementation site, funding sources were inherently different and unique from previous 
locations of protocol implementation.  
Summary 
In summary, successful implementation of this project in a public health setting involved 
thorough planning with multiple stakeholders to achieve successful roll out.  Interprofessional 
collaboration was be paramount in optimizing each step of the process.  It also required staying 
within the boundaries of the project parameters to recruit and enroll the targeted patient 
population.      
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Chapter Six:  Evaluation of the Practice Change Initiative 
The project was implemented for 12 weeks in a North Carolina public health setting. 
Individuals who had a diagnosis of HIV, had never been seen by an HIV specialist, and were 
treatment naïve were included in the project.    
Participant Demographics 
During the time of project implementation, there were a total of seven cases eligible for 
inclusion.  Of these seven, six identified as male and one identified as female.  Three identified 
as Hispanic/Latino, two identified as Black/African American, and two identified as 
White/Caucasian. The median age was 30.1 years with a range from 22 to 38 years of age.       
Intended Outcomes 
The intended outcomes were to 1) link individuals who were newly diagnosed with HIV 
to care as quickly as possible, ideally being seen for a first clinic appointment on the same day as 
diagnosis and 2) start individuals on ART as soon as possible (when clinically appropriate) after 
diagnosis.   
Findings 
 The majority of patients were seen in an HIV clinic < 90 days after diagnosis.   One case 
was seen the same day of diagnosis, three cases were seen within 30 days of diagnosis, two cases 
were seen within 31 to 90 days of diagnosis, and one case was seen >90 days after diagnosis 
(Appendix G).  Of the seven eligible patients, six were started on ART the same day as their first 
clinic appointment. One case was started 4077 days after their day of diagnosis. Five were 
referred through Under One Roof (a case management service), one was a direct internal referral 
from the STI clinic, and one was a direct referral from an outside clinic.  
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Summary 
 In summary, the majority of cases were seen for a first appointment within 30 days of 
diagnosis, while the majority of cases were started on ART the same day as their first 
appointment. Most cases were referred to the clinic from an internal case management service. .    
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Chapter Seven:  Implications for Nursing Practice 
The implementation of this project demonstrates that nurses are well positioned to be at 
the forefront of changing healthcare practice for the good of individuals who are newly 
diagnosed with HIV. The DNP essentials guide the development and implementation of the DNP 
project by creating a framework and roadmap for students throughout the evolution of the project 
(Moran, Burson, & Conrad, 2016).  Furthermore, the DNP essentials help distinguish doctoral 
level education from master’s level education (Moran, Burson, & Conrad, 2016). In addition, 
they help ensure that the DNP projects are safe, effective, patient centered, timely, efficient, and 
equitable (Moran, Burson, & Conrad, 2016).  
Practice Implications 
Essential I:  Scientific underpinnings for practice.   
This essential is defined by analyzing and using information to develop practice, while 
also translating research to improve practice.  Implementation of this project used evidence based 
practice to improve practice outcomes.  The implication is that use of evidence-based practice is 
an integral part of the healthcare delivery system.  Literature was reviewed using a search engine 
and this led to the selection of a protocol and development of an implementation plan, 
subsequently allowing for translation of current evidence in to clinical practice and application. .   
Essential II:  Organization and systems leadership for quality improvement and 
systems thinking.   
Advocacy for improved quality, access, and cost of healthcare contribute to the definition 
of this essential.  Multiple meetings were held before and during the implementation of this 
project to obtain support from key stakeholders. The implication is that advocacy may be an 
important consideration when preparing to implement a quality improvement project. Specific to 
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this project, standard operating procedures were developed in collaboration with the organization 
to successfully implement the project.  The protocol selected for implementation was validated 
and published in a peer reviewed journal.  An approach of beneficence was used to minimize 
ethical risk.  The project was also implemented in a way that did not incur any additional cost to 
the organization. Rather, additionally needed resources came in the additional time needed for 
investment by staff.  
Essential III:  Clinical scholarship and analytical methods for EBP.   
Critical analysis of the literature, application of knowledge, and implementation of 
strategy contribute to this definition.  Implementation of this project was modeled after the 
previously validated UCSF RAPID Start Protocol. The implication is that a literature review is 
an essential component of a quality improvement project.  The literature review overwhelmingly 
revealed that starting on ART is better than a delay with regard to health and outcomes.  It also 
revealed that a rapid start of ART resulted in better retention in to care and decreased time to 
viral suppression. An exploration of the data and evidence showed that the viral suppression rate 
for North Carolina is below the target goal of 90% set by UNAIDS.  This information helped 
develop the project and ensure successful implementation.  
Essential IV:  Information systems/technology and patient care technology for the 
improvement and transformation of healthcare.   
As a component, this essential is defined by the evaluation of systems of care using 
health information technologies. An electronic medical record was used to manage patient health 
records. The implication is that an understanding of healthcare technology is important for 
effectively implementing a quality improvement project. This is important because use of an 
EMR could allow for compiling and aggregating data.  As well, it would also allow for the 
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evaluation of data.  Once available for evaluation, data can be available for comparison and for 
determining if specific goals and targets are being achieved. Use of an EMR also allows for 
longitudinal tracking of data to closely watch change over time.  
Essential V: Healthcare policy for advocacy in healthcare.   
Leadership, organizational influence, education, and advocacy define this essential.  The 
implementation of this project challenged the status quo and presumed standard for expected 
length of time until a first clinic visit and initiation of ART.  It resulted in new standard operating 
procedures being written and new expectations for clinical staff. Stakeholders were also educated 
regarding policies and best practices. The implication is that doctoral prepared nurses will be 
well positioned to lead within the healthcare system. Specifically, it dually served as a 
demonstration project to show other under resourced clinics across the region and nation that 
they, too, can implement rapid start protocols. This would also enable them to improve retention 
in care and decrease time to viral suppression, helping them achieve national goals for HIV care.  
Essential VI:  Interprofessional collaboration for improving patient and population 
health outcomes.   
This is defined by the use of effective collaboration and communication, as well as inter-
professional consultation.  Multiple agencies were utilized in the implementation of this project.  
Contributors included social workers, internal clinics, and outside clinics.  The implication is that 
interprofessional collaboration is a key component of quality improvement within the healthcare 
system.  Healthcare systems commonly rely on multiple disciplines and field specialties to 
effectively deliver quality care to their patients; interprofessional collaboration is imperative to 
this quality delivery. Effective interprofessional collaboration allowed for diverse skill sets to 
holistically contribute to the project.  With each expert making professional contributions to the 
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project, it allowed for optimal care of the patient.  Leadership skills were conveyed through 
advocacy, promotion, and implementation of the rapid care model.   
Essential VII:  Clinical prevention and population health for improving the nation’s 
health.   
This essential is defined by evaluating and implementing change strategies of models of 
health care delivery to improve quality and address diversity.  Faster linkage to care and rapid 
initiation of ART contributes to the United Nations 90-90-90 goal.  They also reduce incidence 
of negative outcomes for individuals living with HIV.  The implication is that evaluation and 
implementation of change strategies are important for quality improvement. A specific goal of 
Healthy People 2020 is that any individual diagnosed with HIV would have a clinic visit with an 
HIV specialist within 30 day of diagnosis.  The implementation of a rapid start protocol is one 
potential option for helping clinics achieve national goals and objectives, including Healthy 
People 2020 goals.  
Essential VIII:  Advanced nursing practice.   
This essential is defined by demonstration of advanced clinical judgment and systematic 
thoughts to improve patient outcomes.  The implementation of nurse practitioner-led care 
contributed to the clinical care that individuals included in this project received.  Through this 
project’s implementation, new standard operation procedures were developed that updated older 
practices and aligned clinical care more in line with current evidence based practice.  The 
implication is that advanced practice nurses are an integral part of advancement within the 
healthcare delivery system.  Critical thinking was used to implement and adapt a protocol 
developed in California and apply it to an under resourced public health clinic in North Carolina.  
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Guidance and mentorship came in the form of educating front line clinical staff on the 
importance of rapid starts.   
Summary 
 In summary, this project implementation met each of the DNP essentials.  Components 
included scientific underpinnings, organizational leadership, clinical scholarship, information 
technology, advocacy, collaboration, clinical prevention, and advanced nursing practice. 
Through the project’s implementation and meeting each of the DNP essentials, implications 
resulted that highlighted the importance of advanced practice nurses within the healthcare 
delivery system.    
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Chapter Eight:  Final Conclusions 
The implementation of this project highlights two separate, but closely related factors in 
the cascade towards viral suppression of HIV: 1) linkage to care and 2) initiation of ART.  More 
importantly, it demonstrates that it is possible to implement a rapid ART start protocol in a 
resource limited setting.  
Significance of Findings 
  The clinical significance of this project is the demonstration that it is possible to 
implement in a resource limited setting the steps proven to improve linkage to care, retention in 
care, and time until viral suppression.  The implication for the patients is better adherence to care 
and fewer missed visits.  Once viral suppression is achieved, HIV cannot be transmitted, leading 
to a reduced transmission rate.  Once suppressed, negative outcomes are reduced, and patient 
health is improved.  
Project Strength and Limitations 
The ability to start an individual on ART the same day as their first clinic visit was found 
to be a strength.  This was facilitated by the sample packs of ART that pharmaceutical 
companies provided to the clinic. Except for one person, all cases were started on ART the same 
day as diagnosis.  The one individual who was not started on ART the same day as their first 
visit was delayed due to a mutual conversation with their PCP who chose to approach their 
initiation the way ART starts have historically been handled.  Follow up appointments were 
appropriately scheduled and kept by the patients.  In addition, the multi-disciplined team that was 
currently in place was found to be a strength, as it streamlined communication amongst the 
multiple disciplines and minimized training and education needed to implement the project. 
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The acceptance of the implementation by staff varied throughout the course of the 
project.  In the beginning there were some clinicians who were completely on board. There were 
also some clinicians who were not completely on board, but became fully accepting of the 
implementation as things progressed.  As implementation resulted in better understanding of 
what successful implementation looked like, all staff were on board and accepting of the concept.  
In result, what was both a liability and strength evolved into a strength.   
The inability to quickly link individuals to care after their diagnosis was found to be a 
limitation. The UCSF protocol utilizes an on-call paging system to link newly diagnosed 
individuals to care, as well as taxi vouchers to transport people to their visit.  Unfortunately, 
these resources were not available for the implementation of this project, and perhaps contributed 
to some patients not being seen for a first clinic visit on the same day of diagnosis. Additionally, 
the city in which the project was implemented for this project lacked the same robust public 
transportation system that San Francisco has historically had.  
This project may be leveraged both locally and nationally and has already been 
implemented in California and Florida prior to this site implementation.  Private clinics may 
have an easier time implementing a rapid care model given more patients with insurance, 
however implementation of the rapid care model in a resource limited public health setting is a 
novel concept.  New technology developments include new ART regimens that pharmaceutical 
companies were actively trying to achieve FDA approval for, and subsequent use in the 
population and use for rapid starts.  
Project Benefits 
The primary benefit of this quality improvement project was the improvement of clinical 
practice.  It challenged the status quo and antiquated practices that some clinicians in the clinic 
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were slow to give up and demonstrated to them that rapid starts are tenable.  It also benefited the 
patients by providing them with the best chance, based on current evidence, of quickly becoming 
virally suppressed and optimizing their health.   
Recommendations for Practice  
Future recommendations for practice include increased efforts to improve linkage to care. 
While this clinic demonstrated that rapid initiation of ART is possible at a resource limited NC 
public health setting, linkage to care proved to be a challenge.  Additional time is needed to work 
with ancillary staff and team members to reduce the time between diagnosis and first clinic visit. 
An increased sample size will add robustness to the data.  In addition, as time progresses, it will 
be possible to correlate those who were rapidly started on ART with time to viral suppression 
and reveal whether results are consistent with other clinics that have implemented rapid start 
models.  The progression of time will also allow for proper evaluation of the project’s 
sustainability.  Whether the implementation of rapid start is still going on at the clinic down the 
road will be an empirical measure of the project’s sustainability.  Plans are also in place to 
submit an abstract to the Conference on Retroviruses and Opportunistic Infections.  Further 
research to be explored includes assessing provider perceptions and feelings about their 
experiences with the implementation of rapid start models.    
Final Summary 
The implementation of this quality improvement project was birthed form the observation 
of a need within a resource limited NC public health system.  Within the field of HIV, research 
and clinical care often coupled together in real time. Much of the ground gained in clinical care 
is the direct result of grass roots advocacy just a few decades ago at a time when HIV did not yet 
have name.  Today, with the advances that have been made and relative ease of medication 
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management, it is hard to imagine that options for treatment were as limited as they once were.  
The rapid start models are one more step on the path towards advancement and an eventual cure.   
While resourced and resource limited clinics may feel that they are operating on different planes, 
a rapid start model is one thing that any clinic, no matter the operating budget, can implement to 
advance clinical care for their patients. In time, more advances will be made. Clinicians engaged 
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Appendix A 
Literature Review Matrix 
Evidence Matrix 
Evidence as the Basis for Practice Change  
 
This evidence table-matrix is provided as a tool to assist students in tracking relevant articles that contain key 
data/evidence found when conducting their literature review. The tool will assist students in recording key articles 
that are relevant to their evidence-based practice (EBP) change project, more importantly, reflecting data/evidence 
to support the “intervention” they identified. The tool should be used continuously as students search the literature. 
Once an article has been selected that clearly contains data/evidence to support the intervention and is being 
considered for inclusion in the final literature review, complete the following exercise:  
1) List each article that contains relevant data/evidence in the table below. Evidence that will be 
included in the final literature review paper.  
2) Across from each article, identify the level of evidence and the “key 
data/evidence/outcomes/findings” associated with that article. Actual data should be listed as 
shown in example below. 
3) Identify what you have concluded from the data/evidence and the article’s overall findings.   
4) Indicate how you will use the article and evidence when planning the practice change project.  
Important note: The evidence matrix should only include articles and data/evidence that support the project. 
Remember, if there is little or no evidence published on how to improve practice specific to the problem, then 
another problem must be identified.  It is not possible to plan an EBP change project if little or no evidence exists.  
Also, when planning the project, each part of the plan must be based on quality evidence.  
In NURS 8269, you will be required to submit your evidence table-matrix (reflecting work completed to date) as 
part of your final course paper submission. Your review of the literature will be an ongoing process, therefore we do 
not expect this to be an all-inclusive table, but a representation of the evidence you have found to date that is in clear 
support of your proposed intervention. In addition, this evidence table-matrix will assist you in writing the findings 
section of the literature review (see guidelines for the Project Paper).  This evidence table-matrix also needs to be 
submitted in subsequent DNP Project Courses as an appendix document with the drafts and final submission of 
the project paper. Students can add rows to the table as needed. 
Levels of Evidence  
Level 1 - Systematic review & meta-analysis of randomized controlled trials; clinical guidelines based on 
systematic reviews or meta-analyses 
Level 2 - One or more randomized controlled trials 
Level 3 - Controlled trial (no randomization) 
Level 4 - Case-control or cohort study 
Level 5 - Systematic review of descriptive & qualitative studies 
Level 6 - Single descriptive or qualitative study 
Level 7 - Expert opinion 
Source: Melnyk, B.M. & Fineout-Overholt, E. (2011). Evidence-based practice in nursing and healthcare: 
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decrease resident 
falls by 50%, 
decrease LOS by 






hours of 4P 
and 6A was 
effective in 
decreasing 





the hours of 4P 
and 6A in the fall 
prevention 
practice change. 
AnanworanichJ, Vandergeeten C, 
Chomchey N, et al. (2013). Early 
ART intervention restricts the 
seeding of the HIV reservoir in 
long-lived central memory CD4+ 
T cells [abstract #47]; Program 
and abstracts of the 20th 




Level I ART during early 
HIV infection 
significantly 
restricts the HIV 
reservoirs 
compared with 
later treatment.  







Adds to the body 




especially on the 
physiologic level.  
Bellan, S. E., Dushoff, J., Galvani, A. 
P., & Meyers, L. A. (2015). 
Reassessment of HIV-1 acute 
phase infectivity: Accounting for 
heterogeneity and study design 
with simulated cohorts. PLoS 
Medicine, 12(3), e1001801. 
doi:10.1371/journal.pmed.10018








infectivity of the 
















b/c of long 
intervals.  





Brenner, B. G., Roger, M., Stephens, D., 
Moisi, D., Hardy, I., Weinberg, J., et al. 
(2011). Transmission clustering drives the 
onward spread of the HIV epidemic among 
men who have sex with men in quebec. The 
Journal of Infectious Diseases, 204(7), 1115-













risk behaviors.  
Simply reinforces 
the importance of 
treatment.  
Cohen MS, Chen YQ, McCauley M, et al. 
Prevention of HIV-1 infection with early 












early ART.  
TEST AND TREAT                                                                               57 





of HIV and 
clinical events 
De Cock, K. M., & El-Sadr, W. M. (2013). 
When to start ART in africa--an urgent 
research priority. The New England Journal 
of Medicine, 368(10), 886-889. 
doi:10.1056/NEJMp1300458 [doi] 
Level I Over time, since 
the 90’s the 
building body of 
knowledge has 
shown that early 
ART improves 
outcomes. The 
authors believe that 
additional clinical 








Girardi, E., Sabin, C. A., & Monforte, A. D. 
(2007). Late diagnosis of HIV infection: 
Epidemiological features, consequences and 
strategies to encourage earlier testing. Journal 
of Acquired Immune Deficiency Syndromes 
(1999), 46 Suppl 1, S3-8. 
doi:10.1097/01.qai.0000286597.57066.2b 
[doi] 
Level I Late presenters to 
care tend to be 
those who perceive 










to control the 
spread of the 
epidemic 
Testing and 





HIV epidemic.  
Grinsztejn, B., Hosseinipour, M. C., 
Ribaudo, H. J., Swindells, S., Eron, J., Chen, 
Y. Q., et al. (2014). Effects of early versus 
delayed initiation of antiretroviral treatment 
on clinical outcomes of HIV-1 infection: 
Results from the phase 3 HPTN 052 
randomised controlled trial. The 




40 vs 61 AIDS 
events in 
participants in 
early vs delayed 
ART group. 498 
(early) vs 585 
(late) 
primary/secondary 
outcomes in earl y 














HIV.gov (2018, June 1). A timeline of HIV 




Level I This is a timeline 
that relies of 
multiple sources to 
provide a historical 
meta analysis 
HIV persists Continued efforts 
are needed to 
stop the HIV 
epidemic.  
Hollingsworth, T. D., Pilcher, C. D., Hecht, 
F. M., Deeks, S. G., & Fraser, C. (2015). 
High transmissibility during early HIV 
infection among men who have sex with 
men-san francisco, california. The Journal of 




Early infection was 
estimated to be a 
highly infectious 
period.  Evidence 
that 
transmissibility is 
not the same across 






limited by the 
short duration 




high rates of 
partner 
change.  





happens early in 
acquisition.  
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INSIGHT START Study Group, Lundgren, J. 
D., Babiker, A. G., Gordin, F., Emery, S., 
Grund, B., et al. (2015). Initiation of 
antiretroviral therapy in early asymptomatic 
HIV infection. The New England Journal of 





in 1.8% of early 
ART initiation vs 




in adults with 
CD4 over 500 
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benefit over 





Jain, V., Hartogensis, W., Bacchetti, P., 
Hunt, P. W., Hatano, H., Sinclair, E., et al. 
(2013). Antiretroviral therapy initiated within 
6 months of HIV infection is associated with 
lower T-cell activation and smaller HIV 
reservoir size. The Journal of Infectious 








than with later 
ART (5.3 vs 7.5%, 
P=.6) and lower 
cell-associated 
RNA levels P 
=0.35 
ART initiation 










term therapy.  
Early ART is 
better than 
delaying.  
Joint United Nations Programme on 
HIV/AIDS. (2013). 90-90-90: An ambitious 
treatment target to help end the AIDS 
epidemic.  Retrieved from 
http://www.unaids.org/sites/default/files/med
ia_asset/90-90-90_en.pdfNational Institute of 
Allergy and Infectious Disease (2015).  
Starting antiretroviral treatment early 
improves outcomes for HIV-Infected 
Indviduals: NIH-funded trial results likely 
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Goal: 90 % 
will be aware 
of status, 90% 
will be on 
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will be virally 
suppressed 
The challenge of 
defeating HIV is 
a global effort.  
North Carolina Public Health (2016). Health 
equity and HIV in North Carolina, 2016: 
Gay, bisexual, and other men who report sex 
with men (MSM) of color have the highest 
estimated rates of HIV in North Carolina. 
Level I  Successful 
treatment leads to 
viral suppression; 
once suppressed, 
HIV cannot be 




Carolina is on 
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North Carolina is 
making progress 
in the effort to 
achieve targets. 8 
Pilcher, C. D., Joaki, G., Hoffman, I. F., 
Martinson, F. E., Mapanje, C., Stewart, P. 
W., et al. (2007). Amplified transmission of 
HIV-1: Comparison of HIV-1 concentrations 
in semen and blood during acute and chronic 





39 of 39 patients 
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happen on the 







Initiating ART on 
the same day of 
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Samji, H., Cescon, A., Hogg, R. S., Modur, 
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was lower for 
individuals with a 
A 20 yo HIV-
positive adult 
on ART in the 
Being on ART is 
imperative to the 
health 
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expectancy among treated HIV-positive 
individuals in the United States and Canada. 
PloS One, 8(12), e81355. 
doi:10.1371/journal.pone.0081355 [doi] 
history of injection 
drug use, non-








live into their 
early 70 s, 





with HIV.  
TEMPRANO ANRS 12136 Study Group. 
Danel C, Moh R, Gabillard D, et al. (2015).  
A Trial of Early Antiretrovirals and Isoniazid 
Preventive Therapy in Africa. N Engl J Med. 
2015 Aug 27;373(9):808–822. Epub 2015 Jul 
20. PubMed PMID: 26193126 
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Early ART is 
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Wake County Human Services. (2017, 
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Wawer, M. J., Gray, R. H., Sewankambo, N. 
K., Serwadda, D., Li, X., Laeyendecker, O., 
et al. (2005). Rates of HIV-1 transmission 
per coital act, by stage of HIV-1 infection, in 
rakai, uganda. The Journal of Infectious 




Rate of HIV 
transmission per 
coital act was 
0.0083/coital act 
w/in 2.5 months 
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the index partner.  
Rate of HIV 
transmission 







may help reduce 
some forms of 
early stage 
infection.  
Zolopa, A., Andersen, J., Powderly, W., 
Sanchez, A., Sanne, I., Suckow, C., et al. 
(2009). Early antiretroviral therapy reduces 
AIDS progression/death in individuals with 
acute opportunistic infections: A multicenter 
randomized strategy trial. PloS One, 4(5), 
e5575. doi:10.1371/journal.pone.0005575 
[doi] 
Level  I AIDS 
progress/death was 
seen in 14% (early) 
vs 24% (late)  
Early ART 
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Appendix B 
WCHS Approval  
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Appendix C 
WCHS Application 
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Appendix D 
Project Data Collection Tool 
DNP Project Data Collection Tool 
 
1. Age? ____________ 
 
2. Gender? _____________ 
 
3. Race/Ethnicity? (circle one below) 
Asian – Black/African American – White – Hispanic/Latino-  
American Indian/Alaska Native – Native Hawaiian/Pacific Islander –  
Mixed Race - Other 
 
4. Was an appointment made and kept for the same day that a reactive HIV test was resulted? 
(circle one) Yes OR No 
  
5. Was antiretroviral therapy (ART) started on the same day as the initial appointment?  
(circle one) Yes OR No 
  
6. What was the mode of scheduling the initial appointment?  
(circle one below)  
Disease Intervention Specialist (DIS) –  
Direct Referral from within Health Department- 
Self-Scheduled – Hospital – Outside Clinic – Other 
 
This data collection tool will be used to collect information that will help describe the population being studied 
within a North Carolina public health setting.  This information will be kept and stored on an Excel spreadsheet for 
analysis that will describe the participants of the quality improvement project.  The tool may be presented in poster, 
paper, or electronic format.  
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Appendix E 
UCSF Rapid Care Model  
 
Pilcher, C. D., Ospina-Norvell, C., Dasgupta, A., Jones, D., Hartogensis, W., Torres, S., et al. 
(2017). The effect of same-day observed initiation of antiretroviral therapy on HIV viral 
load and treatment outcomes in a US public health setting. Journal of Acquired Immune 
Deficiency Syndromes (1999), 74(1), 44-51. doi:10.1097/QAI.0000000000001134 [doi] 
This flow sheet describes the consolidation of events from current practices in to the rapid care  
model and will be used as an illustration to help clinical staff and those involved in direct patient 
care and contact better understand how the rapid care delivery model compares with the current  
process that they are generally accustomed to.  It may be presented in poster, paper, or electronic  
format.  
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Appendix F 





This flow sheet describes the process for rapidly engaging a newly HIV-diagnosed patient in to clinical care in a 
North Carolina public health setting.  It will be used to present the concept to clinical providers and those who may 
have direct patient contact. It may be used in poster, paper, or electronic format.   
 
Follow Up
If contraindication, address issues and start ART 
as soon as safe to do so. 
Schedule follow up appointment within 5-7 days 
to discuss laboratory results and plan of care.  If 
needed, arrange transfer to clinic for ongoing HIV 
pirmary care. 
Initial RAPID Visit: Same day as HIV(+) test if possible
Post-test cousneling and 
education. 
Determine insurance status. 




Blood collected for baseline 
testing.
Offer RAPID ART, if no 
contrindications. 
Positive HIV Test
Patient tests positive at WCHS Clinic A (STI), Clinic 
B (HIV) immeidately notified, offered a same day 
appointment 
Patient tests positive at offsite location (DIS 
directly notifies Clinic B), offered a same day 
appointment                                                    
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Appendix G 









0 days 30 days 31-90 90+
Days until first appointment
